Bruinsma, AafkeKeulen, Judit KJvan Eekelen, Rikvan Wely, MadelonKortekaas, Joep C.van Dillen, Jeroenvan de Post, Joris AMMol, Ben W.de Miranda, Esteriek2023-03-082023-03-082023-03Bruinsma, A, Keulen, J KJ, van Eekelen, R, van Wely, M, Kortekaas, J C, van Dillen, J, van de Post, J AM, Mol, B W & de Miranda, E 2023, 'Cost-effectiveness analysis of induction of labour at 41 weeks and expectant management until 42 weeks in low risk women (INDEX trial)', European Journal of Obstetrics and Gynecology and Reproductive Biology: X, vol. 17, 100178. https://doi.org/10.1016/j.eurox.2023.1001782590-1613https://hdl.handle.net/2164/20240Funding Information: The INDEX trial was supported by a grant from the Netherlands Organisation for Health Research and Development ZonMw (grant No 171202008 ). The grantor had no involvement with the study.103138684engCost-effectivenessExpectant managementInduction of labourLate-term pregnancyPerinatal outcomesR MedicineReproductive MedicineObstetrics and GynaecologyRJournal article10.1016/j.eurox.2023.100178http://www.scopus.com/inward/record.url?scp=85147271084&partnerID=8YFLogxK17